1 A 2025 safety analysis of the SELECT trial found breast cancer rates were 0.7% on semaglutide compared with 0.8% on placebo over more than three years
Choosing between these two prescriptions comes down to your health goals, lifestyle, budget, and comfort level with daily pills versus weekly injections
GLP-1 Insight 27 Changes in behavior can also affect how new products are tested
Carla would be happy to help you get set up with self-administered shots at home
Data and materials availability Upon request, and subject to certain criteria, conditions, and exceptions (see for more information), Pfizer will provide access to individual de-identified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines and medical devices (1) for indications that have been approved in the US and/or EU or (2) in programs that have been terminated (i.e., development for all indications has been discontinued)